Company intelligence / Profile preview

Exphar

Nivelles, Walloon Brabant, Belgiumexphar.com ↗

Ownership: Private
Employees: ~277
Development stage: Other

Overview

Exphar is a leading pharmaceutical company focused on making high-quality, affordable medicines accessible to underserved populations, primarily in Africa. The company has over 40 years of experience and offers around 50 products across more than 25 countries. Its portfolio includes both sterile and non-sterile generic drugs targeting severe or disabling illnesses such as malaria, parasitic diseases, and urogenital conditions. Exphar’s production sites meet European GMP standards.

Therapeutic areas: NephrologyInfectious Diseases
Modalities: Small moleculeGeneric drug
Industry: Biotech

Beyond the preview

Go deeper on Exphar.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Exphar.

Explore the full profile